大人および非伝達性水頭頭症の高齢患者における一次内視鏡第三心房静止術の予後要因の調査
1Neurosurgery Unit, Department of Neuroscience "Rita Levi Montalcini", University of Turin, Turin, Italy.
World neurosurgery
|February 19, 2026
まとめ
エンドスコピーによる第3室内静止術 (ETV) は,成人および高齢者の閉塞性水頭症に対する安全で効果的な治療法です. ETV 成功スコアのような術前要因は,この患者グループにおける長期的な結果を予測することはできません.
科学分野:
- 神経外科は神経外科です.
- 神経学 神経学とは
- 医療技術 医療技術について
背景:
- エンドスコピーによる第三心房静止術 (ETV) は,閉塞性水頭症の主要な治療法である.
- その有効性と予後要因は,小児の集団で確立されています.
- 大人および高齢の患者における予測値については,さらなる調査が必要である.
研究 の 目的:
- 成人および高齢の患者におけるプライマリETV後のシャント機能不全の術前予測要因を評価する.
- この集団におけるETVの長期的な成果を評価する.
主な方法:
- 主要ETVで治療された閉塞性水頭症の成人の患者の遡及評価.
- ETV 成功スコア (ETV-SS) と手術前の放射線学的パラメータの評価.
- 臨床改善,合併症,再検査手術率の分析.
主要な成果:
- 患者の85%がステーマの通路性で良好な結果を達成しました.
- 患者の16%は,平均6.5ヶ月以内にETV不全のためにリビジョン手術を必要とした.
- ETV-SS,年齢,性別,病因,心室形状測定は,長期的な結果と限られた相関を示しました.
結論:
- 成人および高齢のETV患者における手術後の結果を予測する術前予後要因は評価されていません.
- ETVは,様々な年齢層と阻害性水頭症の診断において安全性と有効性を実証しました.
関連する概念動画
Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Aneurysm III: Interprofessional Care
Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Cerebral Edema ll: Pathophysiology
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...


